MarketPeel
EVP R&D, Chief Medical Officer
Tue, Feb 18, 2025
Feb 18
exercised or converted securities in ALKS
8,896 shares @ $0.00
Decreased holdings by -50.00%
Net across this filing: +8.50% (+4,946 shares)
ALKSAlkermes plc.
Health CarePharmaceuticals
1D0.00%
1W-3.05%
1M-8.62%
3M+29.40%
6M
1Y

Recent insider activity at ALKS

FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback